Cargando…
Interstitial lung disease is a dominant feature in patients with circulating myositis-specific antibodies
BACKGROUND: Many patients with polymyositis (PM) or dermatomyositis (DM) have circulating myositis-specific antibodies (MSAs). Interstitial lung disease (ILD) is a common manifestation of PM/DM, and it can even precede the onset of characteristic muscle or skin manifestations. Furthermore, there app...
Autores principales: | Misra, Abhinav K., Wong, Nathan L., Healey, Terrance T., Lally, Edward V., Shea, Barry S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8591876/ https://www.ncbi.nlm.nih.gov/pubmed/34775966 http://dx.doi.org/10.1186/s12890-021-01737-7 |
Ejemplares similares
-
A New Method for the Assessment of Myalgia in Interstitial Lung Disease: Association with Positivity for Myositis-Specific and Myositis-Associated Antibodies
por: Sambataro, Gianluca, et al.
Publicado: (2022) -
In adult onset myositis, the presence of interstitial lung disease and myositis specific/associated antibodies are governed by HLA class II haplotype, rather than by myositis subtype
por: Chinoy, Hector, et al.
Publicado: (2006) -
Predictive Features and Clinical Presentation of Interstitial Lung Disease in Inflammatory Myositis
por: Vojinovic, Tamara, et al.
Publicado: (2020) -
Clinical features and outcomes of patients with myositis associated-interstitial lung disease
por: Karampitsakos, Theodoros, et al.
Publicado: (2023) -
Myositis interstitial lung disease and autoantibodies
por: Chaudhry, Shire, et al.
Publicado: (2023)